ResMed Inc.
ResMed Inc. RSMDF Peers
See (RSMDF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RSMDF | $22.00 | N/A | 26.56B | 24.72 | $0.89 | +0.86% |
| SRTOY | $21.78 | -4.32% | 211.92B | 94.70 | $0.23 | +0.16% |
| ESLOY | $141.79 | +1.43% | 128.98B | 49.92 | $2.84 | +1.04% |
| ESLOF | $281.38 | -0.46% | 128.51B | 49.89 | $5.64 | +1.41% |
| MECNY | $88.63 | N/A | 107.62B | N/A | N/A | N/A |
| SSSGY | $42.51 | +0.95% | 80.68B | 157.44 | $0.27 | +0.41% |
| SOAGY | $51.42 | -0.75% | 80.07B | 165.87 | $0.31 | +0.15% |
| HOCPF | $127.18 | +0.03% | 43.25B | 31.64 | $4.02 | +0.85% |
| HOCPY | $123.81 | +2.40% | 42.68B | 30.88 | $4.01 | +0.42% |
| TRUMF | $19.44 | +9.38% | 28.68B | 34.11 | $0.57 | +1.00% |
Stock Comparison
RSMDF vs SRTOY Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, SRTOY has a market cap of 211.92B. Regarding current trading prices, RSMDF is priced at $22.00, while SRTOY trades at $21.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas SRTOY's P/E ratio is 94.70. In terms of profitability, RSMDF's ROE is +0.25%, compared to SRTOY's ROE of +0.05%. Regarding short-term risk, RSMDF is more volatile compared to SRTOY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs ESLOY Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, ESLOY has a market cap of 128.98B. Regarding current trading prices, RSMDF is priced at $22.00, while ESLOY trades at $141.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas ESLOY's P/E ratio is 49.92. In terms of profitability, RSMDF's ROE is +0.25%, compared to ESLOY's ROE of +0.06%. Regarding short-term risk, RSMDF is more volatile compared to ESLOY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs ESLOF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, ESLOF has a market cap of 128.51B. Regarding current trading prices, RSMDF is priced at $22.00, while ESLOF trades at $281.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas ESLOF's P/E ratio is 49.89. In terms of profitability, RSMDF's ROE is +0.25%, compared to ESLOF's ROE of +0.06%. Regarding short-term risk, RSMDF is more volatile compared to ESLOF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs MECNY Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, MECNY has a market cap of 107.62B. Regarding current trading prices, RSMDF is priced at $22.00, while MECNY trades at $88.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas MECNY's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.25%, compared to MECNY's ROE of +0.02%. Regarding short-term risk, RSMDF is more volatile compared to MECNY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs SSSGY Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, SSSGY has a market cap of 80.68B. Regarding current trading prices, RSMDF is priced at $22.00, while SSSGY trades at $42.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas SSSGY's P/E ratio is 157.44. In terms of profitability, RSMDF's ROE is +0.25%, compared to SSSGY's ROE of +0.05%. Regarding short-term risk, RSMDF is more volatile compared to SSSGY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs SOAGY Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, SOAGY has a market cap of 80.07B. Regarding current trading prices, RSMDF is priced at $22.00, while SOAGY trades at $51.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas SOAGY's P/E ratio is 165.87. In terms of profitability, RSMDF's ROE is +0.25%, compared to SOAGY's ROE of +0.05%. Regarding short-term risk, RSMDF is more volatile compared to SOAGY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs HOCPF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, HOCPF has a market cap of 43.25B. Regarding current trading prices, RSMDF is priced at $22.00, while HOCPF trades at $127.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas HOCPF's P/E ratio is 31.64. In terms of profitability, RSMDF's ROE is +0.25%, compared to HOCPF's ROE of +0.15%. Regarding short-term risk, RSMDF is less volatile compared to HOCPF. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs HOCPY Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, HOCPY has a market cap of 42.68B. Regarding current trading prices, RSMDF is priced at $22.00, while HOCPY trades at $123.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas HOCPY's P/E ratio is 30.88. In terms of profitability, RSMDF's ROE is +0.25%, compared to HOCPY's ROE of +0.15%. Regarding short-term risk, RSMDF is more volatile compared to HOCPY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs TRUMF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, TRUMF has a market cap of 28.68B. Regarding current trading prices, RSMDF is priced at $22.00, while TRUMF trades at $19.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas TRUMF's P/E ratio is 34.11. In terms of profitability, RSMDF's ROE is +0.25%, compared to TRUMF's ROE of +0.07%. Regarding short-term risk, RSMDF is less volatile compared to TRUMF. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs TRUMY Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, TRUMY has a market cap of 27.10B. Regarding current trading prices, RSMDF is priced at $22.00, while TRUMY trades at $18.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas TRUMY's P/E ratio is 32.24. In terms of profitability, RSMDF's ROE is +0.25%, compared to TRUMY's ROE of +0.07%. Regarding short-term risk, RSMDF is more volatile compared to TRUMY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs CLPBF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, CLPBF has a market cap of 22.29B. Regarding current trading prices, RSMDF is priced at $22.00, while CLPBF trades at $99.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas CLPBF's P/E ratio is 33.02. In terms of profitability, RSMDF's ROE is +0.25%, compared to CLPBF's ROE of +0.30%. Regarding short-term risk, RSMDF is less volatile compared to CLPBF. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs SAUHF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, SAUHF has a market cap of 22.10B. Regarding current trading prices, RSMDF is priced at $22.00, while SAUHF trades at $138.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas SAUHF's P/E ratio is 41.50. In terms of profitability, RSMDF's ROE is +0.25%, compared to SAUHF's ROE of +0.14%. Regarding short-term risk, RSMDF is more volatile compared to SAUHF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs SDMHF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, SDMHF has a market cap of 21.50B. Regarding current trading prices, RSMDF is priced at $22.00, while SDMHF trades at $221.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas SDMHF's P/E ratio is 94.04. In terms of profitability, RSMDF's ROE is +0.25%, compared to SDMHF's ROE of +0.05%. Regarding short-term risk, RSMDF is more volatile compared to SDMHF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs CLPBY Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, CLPBY has a market cap of 21.41B. Regarding current trading prices, RSMDF is priced at $22.00, while CLPBY trades at $9.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas CLPBY's P/E ratio is 30.94. In terms of profitability, RSMDF's ROE is +0.25%, compared to CLPBY's ROE of +0.30%. Regarding short-term risk, RSMDF is more volatile compared to CLPBY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs SAUHY Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, SAUHY has a market cap of 21.36B. Regarding current trading prices, RSMDF is priced at $22.00, while SAUHY trades at $13.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas SAUHY's P/E ratio is 39.40. In terms of profitability, RSMDF's ROE is +0.25%, compared to SAUHY's ROE of +0.14%. Regarding short-term risk, RSMDF is more volatile compared to SAUHY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs SARTF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, SARTF has a market cap of 16.42B. Regarding current trading prices, RSMDF is priced at $22.00, while SARTF trades at $212.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas SARTF's P/E ratio is 135.90. In terms of profitability, RSMDF's ROE is +0.25%, compared to SARTF's ROE of +0.05%. Regarding short-term risk, RSMDF is less volatile compared to SARTF. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs SUVPF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, SUVPF has a market cap of 15.80B. Regarding current trading prices, RSMDF is priced at $22.00, while SUVPF trades at $256.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas SUVPF's P/E ratio is 193.09. In terms of profitability, RSMDF's ROE is +0.25%, compared to SUVPF's ROE of +0.05%. Regarding short-term risk, RSMDF is more volatile compared to SUVPF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs OCPNF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, OCPNF has a market cap of 14.27B. Regarding current trading prices, RSMDF is priced at $22.00, while OCPNF trades at $12.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas OCPNF's P/E ratio is 18.33. In terms of profitability, RSMDF's ROE is +0.25%, compared to OCPNF's ROE of +0.10%. Regarding short-term risk, RSMDF is less volatile compared to OCPNF. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs FSPKF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, FSPKF has a market cap of 12.14B. Regarding current trading prices, RSMDF is priced at $22.00, while FSPKF trades at $20.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas FSPKF's P/E ratio is 172.50. In terms of profitability, RSMDF's ROE is +0.25%, compared to FSPKF's ROE of +0.10%. Regarding short-term risk, RSMDF is more volatile compared to FSPKF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs SSMXF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, SSMXF has a market cap of 10.76B. Regarding current trading prices, RSMDF is priced at $22.00, while SSMXF trades at $17.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas SSMXF's P/E ratio is 29.74. In terms of profitability, RSMDF's ROE is +0.25%, compared to SSMXF's ROE of +0.09%. Regarding short-term risk, RSMDF is less volatile compared to SSMXF. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs SSMXY Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, SSMXY has a market cap of 10.57B. Regarding current trading prices, RSMDF is priced at $22.00, while SSMXY trades at $16.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas SSMXY's P/E ratio is 29.22. In terms of profitability, RSMDF's ROE is +0.25%, compared to SSMXY's ROE of +0.09%. Regarding short-term risk, RSMDF is more volatile compared to SSMXY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs CNVVY Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, CNVVY has a market cap of 7.36B. Regarding current trading prices, RSMDF is priced at $22.00, while CNVVY trades at $14.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas CNVVY's P/E ratio is 38.93. In terms of profitability, RSMDF's ROE is +0.25%, compared to CNVVY's ROE of +0.16%. Regarding short-term risk, RSMDF is more volatile compared to CNVVY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs CNVVF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, CNVVF has a market cap of 6.12B. Regarding current trading prices, RSMDF is priced at $22.00, while CNVVF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas CNVVF's P/E ratio is 33.33. In terms of profitability, RSMDF's ROE is +0.25%, compared to CNVVF's ROE of +0.16%. Regarding short-term risk, RSMDF is more volatile compared to CNVVF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs CZMWF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, CZMWF has a market cap of 6.06B. Regarding current trading prices, RSMDF is priced at $22.00, while CZMWF trades at $69.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas CZMWF's P/E ratio is 35.14. In terms of profitability, RSMDF's ROE is +0.25%, compared to CZMWF's ROE of +0.07%. Regarding short-term risk, RSMDF is less volatile compared to CZMWF. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs CZMWY Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, CZMWY has a market cap of 6.05B. Regarding current trading prices, RSMDF is priced at $22.00, while CZMWY trades at $69.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas CZMWY's P/E ratio is 35.11. In terms of profitability, RSMDF's ROE is +0.25%, compared to CZMWY's ROE of +0.07%. Regarding short-term risk, RSMDF is more volatile compared to CZMWY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs YPHDF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, YPHDF has a market cap of 5.70B. Regarding current trading prices, RSMDF is priced at $22.00, while YPHDF trades at $417.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas YPHDF's P/E ratio is 64.11. In terms of profitability, RSMDF's ROE is +0.25%, compared to YPHDF's ROE of +0.13%. Regarding short-term risk, RSMDF is less volatile compared to YPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs FLMNY Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, FLMNY has a market cap of 5.11B. Regarding current trading prices, RSMDF is priced at $22.00, while FLMNY trades at $12.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas FLMNY's P/E ratio is 30.40. In terms of profitability, RSMDF's ROE is +0.25%, compared to FLMNY's ROE of +0.15%. Regarding short-term risk, RSMDF is more volatile compared to FLMNY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs ADDLF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, ADDLF has a market cap of 4.93B. Regarding current trading prices, RSMDF is priced at $22.00, while ADDLF trades at $42.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas ADDLF's P/E ratio is 61.76. In terms of profitability, RSMDF's ROE is +0.25%, compared to ADDLF's ROE of +0.06%. Regarding short-term risk, RSMDF is less volatile compared to ADDLF. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs AHICF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, AHICF has a market cap of 4.39B. Regarding current trading prices, RSMDF is priced at $22.00, while AHICF trades at $16.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas AHICF's P/E ratio is 35.93. In terms of profitability, RSMDF's ROE is +0.25%, compared to AHICF's ROE of +0.07%. Regarding short-term risk, RSMDF is more volatile compared to AHICF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs FLMNF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, FLMNF has a market cap of 3.93B. Regarding current trading prices, RSMDF is priced at $22.00, while FLMNF trades at $46.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas FLMNF's P/E ratio is 23.26. In terms of profitability, RSMDF's ROE is +0.25%, compared to FLMNF's ROE of +0.15%. Regarding short-term risk, RSMDF is more volatile compared to FLMNF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs SHWGY Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, SHWGY has a market cap of 3.00B. Regarding current trading prices, RSMDF is priced at $22.00, while SHWGY trades at $2.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas SHWGY's P/E ratio is 11.52. In terms of profitability, RSMDF's ROE is +0.25%, compared to SHWGY's ROE of +0.09%. Regarding short-term risk, RSMDF is more volatile compared to SHWGY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs SHWGF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, SHWGF has a market cap of 2.98B. Regarding current trading prices, RSMDF is priced at $22.00, while SHWGF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas SHWGF's P/E ratio is 11.00. In terms of profitability, RSMDF's ROE is +0.25%, compared to SHWGF's ROE of +0.09%. Regarding short-term risk, RSMDF is more volatile compared to SHWGF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs ANSLY Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, ANSLY has a market cap of 2.91B. Regarding current trading prices, RSMDF is priced at $22.00, while ANSLY trades at $80.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas ANSLY's P/E ratio is 24.54. In terms of profitability, RSMDF's ROE is +0.25%, compared to ANSLY's ROE of +0.04%. Regarding short-term risk, RSMDF is more volatile compared to ANSLY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs ANSLF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, ANSLF has a market cap of 2.62B. Regarding current trading prices, RSMDF is priced at $22.00, while ANSLF trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas ANSLF's P/E ratio is 22.22. In terms of profitability, RSMDF's ROE is +0.25%, compared to ANSLF's ROE of +0.06%. Regarding short-term risk, RSMDF is more volatile compared to ANSLF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs TCHBF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, TCHBF has a market cap of 2.55B. Regarding current trading prices, RSMDF is priced at $22.00, while TCHBF trades at $200.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas TCHBF's P/E ratio is 32.47. In terms of profitability, RSMDF's ROE is +0.25%, compared to TCHBF's ROE of +0.07%. Regarding short-term risk, RSMDF is more volatile compared to TCHBF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs GRRMF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, GRRMF has a market cap of 2.52B. Regarding current trading prices, RSMDF is priced at $22.00, while GRRMF trades at $73.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas GRRMF's P/E ratio is 20.95. In terms of profitability, RSMDF's ROE is +0.25%, compared to GRRMF's ROE of +0.05%. Regarding short-term risk, RSMDF is more volatile compared to GRRMF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs TCGGY Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, TCGGY has a market cap of 2.31B. Regarding current trading prices, RSMDF is priced at $22.00, while TCGGY trades at $36.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas TCGGY's P/E ratio is 28.35. In terms of profitability, RSMDF's ROE is +0.25%, compared to TCGGY's ROE of +0.07%. Regarding short-term risk, RSMDF is more volatile compared to TCGGY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs EKTAY Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, EKTAY has a market cap of 2.04B. Regarding current trading prices, RSMDF is priced at $22.00, while EKTAY trades at $5.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas EKTAY's P/E ratio is 19.00. In terms of profitability, RSMDF's ROE is +0.25%, compared to EKTAY's ROE of +0.10%. Regarding short-term risk, RSMDF is more volatile compared to EKTAY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs EKTAF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, EKTAF has a market cap of 1.89B. Regarding current trading prices, RSMDF is priced at $22.00, while EKTAF trades at $5.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas EKTAF's P/E ratio is 18.43. In terms of profitability, RSMDF's ROE is +0.25%, compared to EKTAF's ROE of +0.10%. Regarding short-term risk, RSMDF is more volatile compared to EKTAF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs BOEUF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, BOEUF has a market cap of 1.84B. Regarding current trading prices, RSMDF is priced at $22.00, while BOEUF trades at $28.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas BOEUF's P/E ratio is 147.37. In terms of profitability, RSMDF's ROE is +0.25%, compared to BOEUF's ROE of +0.18%. Regarding short-term risk, RSMDF is more volatile compared to BOEUF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs TGLVY Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, TGLVY has a market cap of 1.50B. Regarding current trading prices, RSMDF is priced at $22.00, while TGLVY trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas TGLVY's P/E ratio is 75.00. In terms of profitability, RSMDF's ROE is +0.25%, compared to TGLVY's ROE of +0.02%. Regarding short-term risk, RSMDF is more volatile compared to TGLVY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs NPRRF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, NPRRF has a market cap of 1.50B. Regarding current trading prices, RSMDF is priced at $22.00, while NPRRF trades at $8.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas NPRRF's P/E ratio is 44.74. In terms of profitability, RSMDF's ROE is +0.25%, compared to NPRRF's ROE of N/A. Regarding short-term risk, RSMDF is more volatile compared to NPRRF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs BITGF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, BITGF has a market cap of 1.15B. Regarding current trading prices, RSMDF is priced at $22.00, while BITGF trades at $14.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas BITGF's P/E ratio is 44.14. In terms of profitability, RSMDF's ROE is +0.25%, compared to BITGF's ROE of +0.06%. Regarding short-term risk, RSMDF is less volatile compared to BITGF. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs PBHDF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, PBHDF has a market cap of 1.11B. Regarding current trading prices, RSMDF is priced at $22.00, while PBHDF trades at $19.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas PBHDF's P/E ratio is 12.74. In terms of profitability, RSMDF's ROE is +0.25%, compared to PBHDF's ROE of +0.06%. Regarding short-term risk, RSMDF is more volatile compared to PBHDF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs TDVXF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, TDVXF has a market cap of 1.04B. Regarding current trading prices, RSMDF is priced at $22.00, while TDVXF trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas TDVXF's P/E ratio is 66.00. In terms of profitability, RSMDF's ROE is +0.25%, compared to TDVXF's ROE of +0.39%. Regarding short-term risk, RSMDF is less volatile compared to TDVXF. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs NNCSF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, NNCSF has a market cap of 897.14M. Regarding current trading prices, RSMDF is priced at $22.00, while NNCSF trades at $2.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas NNCSF's P/E ratio is 98.50. In terms of profitability, RSMDF's ROE is +0.25%, compared to NNCSF's ROE of +0.07%. Regarding short-term risk, RSMDF is more volatile compared to NNCSF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs KSRBF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, KSRBF has a market cap of 869.34M. Regarding current trading prices, RSMDF is priced at $22.00, while KSRBF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas KSRBF's P/E ratio is 4.87. In terms of profitability, RSMDF's ROE is +0.25%, compared to KSRBF's ROE of +0.03%. Regarding short-term risk, RSMDF is less volatile compared to KSRBF. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs SPMXF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, SPMXF has a market cap of 550.31M. Regarding current trading prices, RSMDF is priced at $22.00, while SPMXF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas SPMXF's P/E ratio is -18.00. In terms of profitability, RSMDF's ROE is +0.25%, compared to SPMXF's ROE of -0.05%. Regarding short-term risk, RSMDF is more volatile compared to SPMXF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs JNDOF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, JNDOF has a market cap of 531.00M. Regarding current trading prices, RSMDF is priced at $22.00, while JNDOF trades at $22.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas JNDOF's P/E ratio is 47.40. In terms of profitability, RSMDF's ROE is +0.25%, compared to JNDOF's ROE of +0.20%. Regarding short-term risk, RSMDF is more volatile compared to JNDOF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs HGYMF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, HGYMF has a market cap of 524.77M. Regarding current trading prices, RSMDF is priced at $22.00, while HGYMF trades at $24.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas HGYMF's P/E ratio is 33.81. In terms of profitability, RSMDF's ROE is +0.25%, compared to HGYMF's ROE of +0.02%. Regarding short-term risk, RSMDF is more volatile compared to HGYMF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs SAFLY Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, SAFLY has a market cap of 449.61M. Regarding current trading prices, RSMDF is priced at $22.00, while SAFLY trades at $2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas SAFLY's P/E ratio is 223.00. In terms of profitability, RSMDF's ROE is +0.25%, compared to SAFLY's ROE of +0.00%. Regarding short-term risk, RSMDF is less volatile compared to SAFLY. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs CLHLF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, CLHLF has a market cap of 365.45M. Regarding current trading prices, RSMDF is priced at $22.00, while CLHLF trades at $61.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas CLHLF's P/E ratio is 27.93. In terms of profitability, RSMDF's ROE is +0.25%, compared to CLHLF's ROE of +0.12%. Regarding short-term risk, RSMDF is more volatile compared to CLHLF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs SAFLF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, SAFLF has a market cap of 306.46M. Regarding current trading prices, RSMDF is priced at $22.00, while SAFLF trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas SAFLF's P/E ratio is 12.67. In terms of profitability, RSMDF's ROE is +0.25%, compared to SAFLF's ROE of +0.00%. Regarding short-term risk, RSMDF is less volatile compared to SAFLF. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs GUERF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, GUERF has a market cap of 281.03M. Regarding current trading prices, RSMDF is priced at $22.00, while GUERF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas GUERF's P/E ratio is 8.19. In terms of profitability, RSMDF's ROE is +0.25%, compared to GUERF's ROE of N/A. Regarding short-term risk, RSMDF is more volatile compared to GUERF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs TSNLF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, TSNLF has a market cap of 252.35M. Regarding current trading prices, RSMDF is priced at $22.00, while TSNLF trades at $5.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas TSNLF's P/E ratio is 33.06. In terms of profitability, RSMDF's ROE is +0.25%, compared to TSNLF's ROE of +0.21%. Regarding short-term risk, RSMDF is more volatile compared to TSNLF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs OPSSF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, OPSSF has a market cap of 247.43M. Regarding current trading prices, RSMDF is priced at $22.00, while OPSSF trades at $2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas OPSSF's P/E ratio is -26.74. In terms of profitability, RSMDF's ROE is +0.25%, compared to OPSSF's ROE of -0.17%. Regarding short-term risk, RSMDF is more volatile compared to OPSSF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs UEEC Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, UEEC has a market cap of 64.15M. Regarding current trading prices, RSMDF is priced at $22.00, while UEEC trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas UEEC's P/E ratio is -24.95. In terms of profitability, RSMDF's ROE is +0.25%, compared to UEEC's ROE of +1.31%. Regarding short-term risk, RSMDF is less volatile compared to UEEC. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs EEOIF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, EEOIF has a market cap of 63.38M. Regarding current trading prices, RSMDF is priced at $22.00, while EEOIF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas EEOIF's P/E ratio is -2.42. In terms of profitability, RSMDF's ROE is +0.25%, compared to EEOIF's ROE of N/A. Regarding short-term risk, RSMDF is more volatile compared to EEOIF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs IMTH Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, IMTH has a market cap of 31.51M. Regarding current trading prices, RSMDF is priced at $22.00, while IMTH trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas IMTH's P/E ratio is -1.54. In terms of profitability, RSMDF's ROE is +0.25%, compared to IMTH's ROE of +2.29%. Regarding short-term risk, RSMDF is more volatile compared to IMTH. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs GVDI Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, GVDI has a market cap of 16.21M. Regarding current trading prices, RSMDF is priced at $22.00, while GVDI trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas GVDI's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.25%, compared to GVDI's ROE of +0.00%. Regarding short-term risk, RSMDF is less volatile compared to GVDI. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs OTCFF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, OTCFF has a market cap of 11.03M. Regarding current trading prices, RSMDF is priced at $22.00, while OTCFF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas OTCFF's P/E ratio is -12.78. In terms of profitability, RSMDF's ROE is +0.25%, compared to OTCFF's ROE of +18.74%. Regarding short-term risk, RSMDF is more volatile compared to OTCFF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs YBGJ Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, YBGJ has a market cap of 10.66M. Regarding current trading prices, RSMDF is priced at $22.00, while YBGJ trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas YBGJ's P/E ratio is -4.45. In terms of profitability, RSMDF's ROE is +0.25%, compared to YBGJ's ROE of +3.46%. Regarding short-term risk, RSMDF is more volatile compared to YBGJ. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs TEVNF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, TEVNF has a market cap of 7.45M. Regarding current trading prices, RSMDF is priced at $22.00, while TEVNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas TEVNF's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.25%, compared to TEVNF's ROE of +3.22%. Regarding short-term risk, RSMDF is less volatile compared to TEVNF. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs BLMHF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, BLMHF has a market cap of 5.22M. Regarding current trading prices, RSMDF is priced at $22.00, while BLMHF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas BLMHF's P/E ratio is 1.56. In terms of profitability, RSMDF's ROE is +0.25%, compared to BLMHF's ROE of N/A. Regarding short-term risk, RSMDF is more volatile compared to BLMHF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs PXMVF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, PXMVF has a market cap of 4.62M. Regarding current trading prices, RSMDF is priced at $22.00, while PXMVF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas PXMVF's P/E ratio is -0.17. In terms of profitability, RSMDF's ROE is +0.25%, compared to PXMVF's ROE of N/A. Regarding short-term risk, RSMDF is less volatile compared to PXMVF. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs RSCF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, RSCF has a market cap of 4.29M. Regarding current trading prices, RSMDF is priced at $22.00, while RSCF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas RSCF's P/E ratio is -5.01. In terms of profitability, RSMDF's ROE is +0.25%, compared to RSCF's ROE of +0.08%. Regarding short-term risk, RSMDF is more volatile compared to RSCF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs ECIA Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, ECIA has a market cap of 4.28M. Regarding current trading prices, RSMDF is priced at $22.00, while ECIA trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas ECIA's P/E ratio is -9.00. In terms of profitability, RSMDF's ROE is +0.25%, compared to ECIA's ROE of -0.33%. Regarding short-term risk, RSMDF is less volatile compared to ECIA. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs MCDA Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, MCDA has a market cap of 4.24M. Regarding current trading prices, RSMDF is priced at $22.00, while MCDA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas MCDA's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.25%, compared to MCDA's ROE of N/A. Regarding short-term risk, RSMDF is more volatile compared to MCDA. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs CBSC Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, CBSC has a market cap of 3.82M. Regarding current trading prices, RSMDF is priced at $22.00, while CBSC trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas CBSC's P/E ratio is -3.39. In terms of profitability, RSMDF's ROE is +0.25%, compared to CBSC's ROE of +1.52%. Regarding short-term risk, RSMDF is less volatile compared to CBSC. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs NSTGQ Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, NSTGQ has a market cap of 3.31M. Regarding current trading prices, RSMDF is priced at $22.00, while NSTGQ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas NSTGQ's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.25%, compared to NSTGQ's ROE of N/A. Regarding short-term risk, RSMDF is more volatile compared to NSTGQ. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs TUTH Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, TUTH has a market cap of 629427.00. Regarding current trading prices, RSMDF is priced at $22.00, while TUTH trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas TUTH's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.25%, compared to TUTH's ROE of N/A. Regarding short-term risk, RSMDF is more volatile compared to TUTH. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs OJSY Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, OJSY has a market cap of 454285.00. Regarding current trading prices, RSMDF is priced at $22.00, while OJSY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas OJSY's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.25%, compared to OJSY's ROE of N/A. Regarding short-term risk, RSMDF is more volatile compared to OJSY. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs REMI Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, REMI has a market cap of 399920.00. Regarding current trading prices, RSMDF is priced at $22.00, while REMI trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas REMI's P/E ratio is -2.00. In terms of profitability, RSMDF's ROE is +0.25%, compared to REMI's ROE of -0.08%. Regarding short-term risk, RSMDF is less volatile compared to REMI. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs PDMI Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, PDMI has a market cap of 324879.00. Regarding current trading prices, RSMDF is priced at $22.00, while PDMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas PDMI's P/E ratio is -0.01. In terms of profitability, RSMDF's ROE is +0.25%, compared to PDMI's ROE of +0.19%. Regarding short-term risk, RSMDF is more volatile compared to PDMI. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs WHSI Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, WHSI has a market cap of 182671.00. Regarding current trading prices, RSMDF is priced at $22.00, while WHSI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas WHSI's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.25%, compared to WHSI's ROE of +0.84%. Regarding short-term risk, RSMDF is more volatile compared to WHSI. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs CEOS Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, CEOS has a market cap of 130130.00. Regarding current trading prices, RSMDF is priced at $22.00, while CEOS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas CEOS's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.25%, compared to CEOS's ROE of +1.18%. Regarding short-term risk, RSMDF is less volatile compared to CEOS. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs QTXB Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, QTXB has a market cap of 118045.00. Regarding current trading prices, RSMDF is priced at $22.00, while QTXB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas QTXB's P/E ratio is -0.05. In terms of profitability, RSMDF's ROE is +0.25%, compared to QTXB's ROE of +0.00%. Regarding short-term risk, RSMDF is less volatile compared to QTXB. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs LANZ Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, LANZ has a market cap of 27690.00. Regarding current trading prices, RSMDF is priced at $22.00, while LANZ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas LANZ's P/E ratio is 1.00. In terms of profitability, RSMDF's ROE is +0.25%, compared to LANZ's ROE of N/A. Regarding short-term risk, RSMDF is more volatile compared to LANZ. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs GMVDF Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, GMVDF has a market cap of 25992.00. Regarding current trading prices, RSMDF is priced at $22.00, while GMVDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas GMVDF's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.25%, compared to GMVDF's ROE of N/A. Regarding short-term risk, RSMDF is more volatile compared to GMVDF. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs ASFX Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, ASFX has a market cap of 17502.00. Regarding current trading prices, RSMDF is priced at $22.00, while ASFX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas ASFX's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.25%, compared to ASFX's ROE of +0.00%. Regarding short-term risk, RSMDF is more volatile compared to ASFX. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs INND Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, INND has a market cap of 15853.00. Regarding current trading prices, RSMDF is priced at $22.00, while INND trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas INND's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.25%, compared to INND's ROE of +0.32%. Regarding short-term risk, RSMDF is less volatile compared to INND. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs MDIT Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, MDIT has a market cap of 8620.00. Regarding current trading prices, RSMDF is priced at $22.00, while MDIT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas MDIT's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.25%, compared to MDIT's ROE of -0.99%. Regarding short-term risk, RSMDF is more volatile compared to MDIT. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs DGEN Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, DGEN has a market cap of 3859.00. Regarding current trading prices, RSMDF is priced at $22.00, while DGEN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas DGEN's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.25%, compared to DGEN's ROE of N/A. Regarding short-term risk, RSMDF is more volatile compared to DGEN. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs LFPI Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, LFPI has a market cap of 2042.00. Regarding current trading prices, RSMDF is priced at $22.00, while LFPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas LFPI's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.25%, compared to LFPI's ROE of -4.85%. Regarding short-term risk, RSMDF is less volatile compared to LFPI. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs BLFE Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, BLFE has a market cap of 1567.00. Regarding current trading prices, RSMDF is priced at $22.00, while BLFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas BLFE's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.25%, compared to BLFE's ROE of +0.00%. Regarding short-term risk, RSMDF is more volatile compared to BLFE. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs SVSO Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, SVSO has a market cap of 1276.00. Regarding current trading prices, RSMDF is priced at $22.00, while SVSO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas SVSO's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.25%, compared to SVSO's ROE of +0.17%. Regarding short-term risk, RSMDF is less volatile compared to SVSO. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs SEYE Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, SEYE has a market cap of 1159.00. Regarding current trading prices, RSMDF is priced at $22.00, while SEYE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas SEYE's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.25%, compared to SEYE's ROE of N/A. Regarding short-term risk, RSMDF is more volatile compared to SEYE. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs BGMD Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, BGMD has a market cap of 1100.00. Regarding current trading prices, RSMDF is priced at $22.00, while BGMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas BGMD's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.25%, compared to BGMD's ROE of +0.00%. Regarding short-term risk, RSMDF is less volatile compared to BGMD. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs ADLI Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, ADLI has a market cap of 1039.00. Regarding current trading prices, RSMDF is priced at $22.00, while ADLI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas ADLI's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.25%, compared to ADLI's ROE of +1.36%. Regarding short-term risk, RSMDF is less volatile compared to ADLI. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs VSMD Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, VSMD has a market cap of 801.00. Regarding current trading prices, RSMDF is priced at $22.00, while VSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas VSMD's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.25%, compared to VSMD's ROE of +3.15%. Regarding short-term risk, RSMDF is less volatile compared to VSMD. This indicates potentially lower risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs HRAL Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, HRAL has a market cap of 495.00. Regarding current trading prices, RSMDF is priced at $22.00, while HRAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas HRAL's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.25%, compared to HRAL's ROE of +0.13%. Regarding short-term risk, RSMDF is more volatile compared to HRAL. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs SDCCQ Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, SDCCQ has a market cap of 403.00. Regarding current trading prices, RSMDF is priced at $22.00, while SDCCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas SDCCQ's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.25%, compared to SDCCQ's ROE of -0.61%. Regarding short-term risk, RSMDF is more volatile compared to SDCCQ. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs MICRD Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, MICRD has a market cap of 317.00. Regarding current trading prices, RSMDF is priced at $22.00, while MICRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas MICRD's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.25%, compared to MICRD's ROE of -0.25%. Regarding short-term risk, RSMDF is more volatile compared to MICRD. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs RGBOQ Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, RGBOQ has a market cap of 97.00. Regarding current trading prices, RSMDF is priced at $22.00, while RGBOQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas RGBOQ's P/E ratio is -0.00. In terms of profitability, RSMDF's ROE is +0.25%, compared to RGBOQ's ROE of N/A. Regarding short-term risk, RSMDF is more volatile compared to RGBOQ. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs SECI Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, SECI has a market cap of 31.00. Regarding current trading prices, RSMDF is priced at $22.00, while SECI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas SECI's P/E ratio is N/A. In terms of profitability, RSMDF's ROE is +0.25%, compared to SECI's ROE of -0.00%. Regarding short-term risk, RSMDF is more volatile compared to SECI. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.
RSMDF vs VTEQ Comparison
RSMDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RSMDF stands at 26.56B. In comparison, VTEQ has a market cap of 1.00. Regarding current trading prices, RSMDF is priced at $22.00, while VTEQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RSMDF currently has a P/E ratio of 24.72, whereas VTEQ's P/E ratio is -0.00. In terms of profitability, RSMDF's ROE is +0.25%, compared to VTEQ's ROE of N/A. Regarding short-term risk, RSMDF is more volatile compared to VTEQ. This indicates potentially higher risk in terms of short-term price fluctuations for RSMDF.